Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

WaVe Life Sciences

WaVe Life Sciences
$21.34 SHARE PRICE (As of Friday Closing)

WAVE Life Sciences Ltd is a preclinical biopharmaceutical company based in Singapore. It owns a diverse pipeline of nucleic acid therapeutics meant to address rare genetic diseases related to the central nervous system, muscles, eyes, liver, and skin. Its nucleic acid therapeutics target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins.

Formerly Known As
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Stock Exchange
Primary Office
  • 733 Concord Avenue
  • Cambridge, MA 02138
  • United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore WaVe Life Sciences’s full profile, request a free trial.

WaVe Life Sciences Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$18.16 - $56.00 $732M $21.77 -$5.14 255K 34.3M

WaVe Life Sciences Financials Summary

In Thousands,
FY 2018
FY 2017
FY 2016
Enterprise Value 648,971 1,036,040 822,745 452,836
Revenue 18,767 14,414 3,893 1,092
EBITDA (154,208) (141,025) (98,989) (54,731)
Net Income (161,660) (146,653) (101,980) (55,660)
Total Assets 385,547 295,940 181,843 164,811
Total Debt 34,009 10,403 3,454 78
Public Fundamental Data provided by Morningstar, Inc. disclaimer

WaVe Life Sciences Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
Debt Status

This information is reserved for PitchBook Platform users. To explore WaVe Life Sciences‘s full profile, request access.

Request full access to PitchBook

WaVe Life Sciences Competitors (42)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Homology Medicines Formerly VC-backed Bedford, MA 000 00000 00000000 00000
0000000 0000000000 Formerly VC-backed Richmond, CA 000 000.00 00000000 000.00
000000000 00000000 Formerly VC-backed Zurich, Switzerland 000 00000 00000000000 00000
00000000 000000000 Formerly VC-backed San Francisco, CA 000 00000 00000000000 00000
000000000 00000000 Formerly VC-backed San Diego, CA 00 00000 00000000 00000
To view this company’s complete list of competitors, request access »

WaVe Life Sciences Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore WaVe Life Sciences‘s full profile, request access.

Request full access to PitchBook

WaVe Life Sciences Executive Team (6)

Name Title Board
Paul Bolno MD Chief Executive Officer & Board Member
Keith Regnante Chief Financial Officer & Chief Accounting Officer
Christopher Francis Ph.D Executive & Senior Vice President
Kyle Moran Vice President & Head, Finance
Chandra Vargeese Ph.D Senior Vice President

1 Former Executive

You’re viewing 5 of 6 executives. Get the full list »

WaVe Life Sciences Board Members (8)

Name Representing Role Since Contact
Adrian Rawcliffe Self Board Member 000 0000
Christian Henry Self Chairman & Board Member 000 0000
Gregory Verdine Ph.D WaVe Life Sciences Board Member & Founder 000 0000
Ken Takanashi Self Board Member 000 0000
Koji Miura Self Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »